Literature DB >> 19209754

Epidemiology of Plasmodium falciparum and P. vivax malaria endemic in northern Afghanistan.

Michael K Faulde1, Ralf Hoffmann, Khair M Fazilat, Achim Hoerauf.   

Abstract

In 2002, the total malaria burden in Afghanistan was estimated to be 3 million cases annually, mainly from Takhar and Kunduz Provinces. Field investigations from 2001 to 2007 revealed a rapid resurgence of Plasmodium falciparum & P. vivax malaria, with annual incidence rates between 0.0026 & 4.39, and between 0.88 & 13.37 episodes/1,000 person years, respectively. Both diseases peaked during 2002, and then declined independently, indicating two differing modes of transmission and epidemiology. Although control campaigns against malaria tropica, transmitted by the freshwater breeder Anopheles superpictus, were successful, malaria tertiana remained endemic and associated with rice-growing areas, transmitted by the anthropophilic, endophilic or exophilic rice-field breeder, A. pulcherrimus and A. hyrcanus. P. vivax polymorph VK 247 prevailed in 90% of infected mosquito pools. Data documented anthropogenically induced increases in rice-field malaria tertiana in the rice-growing areas of northern Afghanistan and the need for further control strategies, including large-scale larval mosquito eradication in rice-growing areas.

Entities:  

Mesh:

Year:  2008        PMID: 19209754

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  2 in total

1.  Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.

Authors:  Ghulam Rahim Awab; Sasithon Pukrittayakamee; Mallika Imwong; Arjen M Dondorp; Charles J Woodrow; Sue Jean Lee; Nicholas P J Day; Pratap Singhasivanon; Nicholas J White; Faizullah Kaker
Journal:  Malar J       Date:  2010-04-21       Impact factor: 2.979

2.  Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.

Authors:  Ghulam Rahim Awab; Mallika Imwong; Sasithon Pukrittayakamee; Fazel Alim; Warunee Hanpithakpong; Joel Tarning; Arjen M Dondorp; Nicholas P J Day; Nicholas J White; Charles J Woodrow
Journal:  Malar J       Date:  2016-02-25       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.